The U.S. is preparing to roll out rules that will impact global AI development — and it’s reportedly getting pushback on them from foreign government officials and tech company leaders.
At the same time, new rules in China could negatively impact Nvidia’s chip business in the country.
Read about it and more in this week’s AI news roundup.
OpenAI is delaying the rollout of ChatGPT’s latest image generation features, Images in ChatGPT, for users on its free subscription tier, CEO Sam Altman said in an X post on Wednesday.
After the U.S. placed chip-export controls on China in October 2022 to curb the country’s technological advances, U.S.-based chipmaker Nvidia (NVDA) designed less-powerful versions of its artificial intelligence chips to continue its presence in the Chinese market while complying with the rules.
Artificial intelligence giant OpenAI expects to see its revenue more than triple to hit $12.7 billion by the end of the year, Bloomberg reported, citing an undisclosed source familiar with the matter.
As the U.S. prepares to roll out rules that will affect global artificial intelligence development, foreign government officials and tech company leaders are asking the Trump administration to relax some rules around chips, according to Bloomberg.
It’s an April Fools’ Day miracle.
The race to build out data centers for artificial intelligence is worrying one billionaire.
From the buzz around AI agents that can work on behalf of humans, to the inevitable rollout of AI tools in the workplace, employees across industries are concerned about the possibility of eventually being replaced by automation.
OpenAI’s release of ChatGPT in November 2022 spurred a race to develop advanced generative artificial intelligence models — one that has seen some companies shell out tens of billions of dollars on AI infrastructure. But that’s not the only place major spending is happening.
A version of this article originally appeared in Quartz’s members-only Weekend Brief newsletter. Quartz members get access to exclusive newsletters and more. Sign up here.
